Legal & General Group Plc Acquires 52,863 Shares of Sotera Health Company $SHC

Legal & General Group Plc grew its holdings in Sotera Health Company (NASDAQ:SHC) by 20.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 308,389 shares of the company’s stock after purchasing an additional 52,863 shares during the quarter. Legal & General Group Plc’s holdings in Sotera Health were worth $5,440,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in SHC. IFP Advisors Inc grew its position in Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares in the last quarter. True Wealth Design LLC boosted its holdings in shares of Sotera Health by 389.3% during the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after buying an additional 1,456 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the period. Allworth Financial LP boosted its holdings in shares of Sotera Health by 922.0% during the 4th quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock worth $53,000 after buying an additional 2,729 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Sotera Health by 31.1% during the 4th quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock worth $86,000 after buying an additional 1,161 shares during the period. 91.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on SHC. Barclays decreased their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Finally, Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and an average target price of $20.29.

Sotera Health Price Performance

NASDAQ:SHC opened at $15.62 on Monday. The company has a 50-day moving average of $15.37 and a 200-day moving average of $16.37. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of 38.10 and a beta of 1.79. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities research analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 15.36% of the stock is owned by company insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.